A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Non-small Cell Lung Cancer|Metastatic Colorectal Cancer|Metastatic Breast Cancer|Metastatic Kidney Cancer|Cervical Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
Interventions: DRUG: Zirabev
Sponsor: Pfizer